Third National Health and Nutrition Examination Survey (NHANES III), 1988-94 NHANES III PRESCRIPTION MEDICINES DATA FILE DOCUMENTATION Series 11, No. 2A April 1998 Table of Contents Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Guidelines for Data Users. . . . . . . . . . . . . . . . . . . . . . . . Survey Description . . . . . . . . . . . . . . . . . . . . . . . . . . . Sample Design and Analysis Guidelines. . . . . . . . . . . . . . . . . . Data Preparation and Processing Procedures . . . . . . . . . . . . . . . General References . . . . . . . . . . . . . . . . . . . . . . . . . . . NHANES III Prescription Medicines Data File General Information . . . . . . . . . . . . . . . . . . . . . . . . Data File Index . . . . . . . . . . . . . . . . . . . . . . . . . . Data File Item Descriptions, Codes, Counts, and Notes . . . . . . . Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . Introduction The National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC) collects, analyzes, and disseminates data on the health status of U.S. residents. The results of surveys, analyses, and studies are made known through a number of data release mechanisms including publications, mainframe computer data files, CD-ROMs (Search and Retrieval Software, Statistical Export and Tabulation System (SETS)), and the Internet. The National Health and Nutrition Examination Survey (NHANES) is a periodic survey conducted by NCHS. The third National Health and Nutrition Examination Survey (NHANES III), conducted from 1988 through 1994, was the seventh in a series of these surveys based on a complex, multi-stage sample plan. It was designed to provide national estimates of the health and nutritional status of the United States' civilian, noninstitutionalized population aged two months and older. The following table summarizes the NHANES III data which are currently available on CD-ROM, including this release. Table 1. Available NHANES III CD-ROMs +----------------------+-------+---------+------------------------------------+ |CD-ROM Name |Release|Size in |Data Files / Description | | |Date |Megabytes| | +----------------------+-------+---------+------------------------------------+ |NHANES III, 1988-94, |April | 407 |Dietary recall (replacement), | |Series 11, No. 2A, |1998 | |electrocardiography, laboratory | |ASCII Version (this | | |(additional analytes), and | |release) | | |vitamins/medicines data files and | | | | |documentation | +----------------------+-------+---------+------------------------------------+ |NHANES III, 1988-94, |October| 285 |Adult and youth household | |Series 11, No. 1, |1997 | |questionnaire, examination, and | |Revised SETS Version | | |laboratory data files and | |1.22a | | |documentation, plan and operation, | | | | |analytic and reporting guidelines, | | | | |weighting and estimation | | | | |methodology, field operations, | | | | |non-response bias | +----------------------+-------+---------+------------------------------------+ |NHANES III, 1988-94, |July | 454 |Adult and youth household | |Series 11, No. 1A, |1997 | |questionnaire, dietary recall, | |ASCII Version | | |examination, and laboratory data | | | | |files and documentation | +----------------------+-------+---------+------------------------------------+ |NHANES III, 1988-94, |July | 285 |Adult and youth household | |Series 11, No. 1, |1997 | |questionnaire, examination, and | |SETS Version 1.22a * | | |laboratory data files and | | | | |documentation | +----------------------+-------+---------+------------------------------------+ |NHANES III Reference |October| 152 |Plan and operation, analytic and | |Manuals and Reports |1996 | |reporting guidelines, weighting and | |October 1996 | | |estimation methodology, field | | | | |operations, non-response bias | +----------------------+-------+---------+------------------------------------+ * Do not use this CD-ROM It had technical problems and has been superseded by the revised SETS version 1.22a, Series 11, No. 1, released in October 1997. This release, Series 11, No. 2A, contains previously unreleased data and corrections. Corrections were made to the vitamin/minerals portion of the adult and youth questionnaire data files as well as the dietary recall portion of the examination data file. For the laboratory component, some previously release variables have been augmented with NHANES III Phase 2 data. In addition several new laboratory variables have been added. The following table shows which public use files contain information from the interview and examination components. Table 2. Location of the interview and examination components in the NHANES III public use data files Data File Topic | HA | HY | EXAM | LAB | DIET | VMS | ECG | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Sample weights | X | X | X | X | . | . | X | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Age/race/sex | X | X | X | X | . | . | X | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Ethnic background | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Household composition | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Individual characteristics | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Health insurance | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Family background | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Occupation of family head | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Housing characteristics | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Family characteristics | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Orientation | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Health services | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Selected health conditions | X | X | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Diabetes questions | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ High blood pressure and | X | . | . | . | . | . | . | cholesterol questions | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Cardiovascular disease | X | . | . | . | . | . | . | questions | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Musculoskeletal conditions | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Physical functioning | X | . | . | . | . | . | . | questions | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Gallbladder disease | X | . | . | . | . | . | . | questions | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Table 2. (continued) Location of the interview and examination components in the NHANES III public use data files Data File Topic | HA | HY | EXAM | LAB | DIET | VMS | ECG | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Kidney conditions | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Respiratory and allergy | X | X | . | . | . | . | . | questions | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Diet questions | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Food frequency | X | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Vision questions | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Hearing questions | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Dental care and status | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Tobacco | X | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Occupation | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Language usage | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Exercise | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Social support/residence | X | . | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Vitamin/mineral/medicine | X | X | X | . | . | . | . | usage | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Blood pressure measurement | X | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Birth | . | X | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Infant feeding | . | X | . | . | . | . | . | practices/diet | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Motor and social development | . | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Functional impairment | X | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ School attendance | . | X | . | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Cognitive function | . | X | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Table 2. (continued) Location of the interview and examination components in the NHANES III public use data files Data File Topic | HA | HY | EXAM | LAB | DIET | VMS | ECG | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Alcohol and drug use | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Reproductive health | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Diagnostic interview | . | . | X | . | . | . | . | schedule | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Activity | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Physician's examination | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Height and weight | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Body measurements | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Dental examination | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Allergy skin test | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Audiometry | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Tympanometry | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ WISC and WRAT | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Spirometry | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Bone densitometry | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Gallbladder ultrasonography | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Central nervous system | . | . | X | . | . | . | . | function evaluation | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Fundus photography | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Physical function evaluation | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Fasting questions | . | . | . | X | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Table 2. (continued) Location of the interview and examination components in the NHANES III public use data files Data File Topic | HA | HY | EXAM | LAB | DIET | VMS | ECG | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Laboratory tests on blood | . | . | . | X | . | . | . | and urine | | | | | | | | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Total nutrient intakes | . | . | X | . | . | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Individual foods | . | . | . | . | X | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Combination foods | . | . | . | . | X | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Ingredients | . | . | . | . | X | . | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Prescription Medicines | X | X | . | . | . | X | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Vitamins and Minerals | X | X | . | . | . | X | . | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Electrocardiography | . | . | . | . | . | . | X | ------------------------------+-----+-----+-------+-----+------+-----+-----+ Data File Definitions HA - Household Adult Data File HY - Household Youth Data File EXAM - Examination Data File LAB - Laboratory Data File and Second Laboratory Data File DIET - Dietary Recall Data Files VMS - Vitamin Mineral Supplement Data File ECG - Electrocardiography Data File This document includes the documentation for the NHANES III Prescription Medicines Data File and also contains a general overview of the survey and the use of the data files. The general overview includes five sections. The first section, entitled "Guidelines for Data Users," contains important information about the use of the data files. The second section, "Survey Description," is a brief overview of the survey plan and operation. The third section, "Sample Design and Analysis Guidelines," describes some technical aspects of the sampling plan and discusses some analytic issues particularly related to the use of data from complex sample surveys. The "Data Preparation and Processing Procedures" section describes the editing conventions and the codes used to represent the data. The last and fifth section, "General References," includes a reference list for the survey overview sections of the document. Public Use Data Files for the third National Health and Nutrition Examination Survey will also be available from the National Technical Information Service (NTIS). A list of NCHS public use data tapes available for purchase from NTIS may be obtained from the Data Dissemination Branch at NCHS. Information regarding a bibliography (on disk) of journal articles citing data from all the NHANES and the availability of NHANES III data in CD-ROM/SETS software format can be obtained from the Data Dissemination Branch at: Data Dissemination Branch National Center for Health Statistics Room 1018 6525 Belcrest Road Hyattsville, Maryland 20782 Phone: (301)436-8500 URL:http://www.cdc.gov/nchswww NTIS can be contacted at: NTIS - Computer Products Office 5285 Port Royal Road Springfield, Virginia 22161 (703) 487-4807 Copies of all NHANES III questionnaires and data collection forms are included in the Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94 (NCHS, 1994; U.S. DHHS, 1996). This publication, along with detailed information on NHANES procedures, interviewing, data collection, quality control techniques, survey design, nonresponse, and sample weighting can be found on the NHANES III Reference Manuals and Reports CD-ROM (U.S. DHHS, 1996). Information on how to order this CD-ROM is also available from the Data Dissemination Branch at NCHS at the address and telephone number given above. GUIDELINES FOR DATA USERS Please refer to the following important information before analyzing data. NHANES III Background Documents o The Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94, (NCHS, 1994; U.S. DHHS, 1996) provides an overview of the survey and includes copies of the survey forms. o The sample design, nonresponse, and analytic guidelines documents on the NHANES III Reference Manuals and Reports CD-ROM (U.S. DHHS, 1996) discuss the reasons that sample weights and the complex survey design should be taken into account when conducting any analysis. o Instruction manuals, laboratory procedures, and other NHANES III reference manuals on the NHANES III Reference Manuals and Reports CD-ROM(U.S. DHHS, 1996) are also available for further information on the details of the survey. Analytic Data Set Preparation o Most NHANES III survey design and demographic variables are found only on the Adult and Youth Household Data Files available on the first release. In preparing a data set for analysis, other data files must be merged with either or both of these files to obtain many important analytic variables. o All of the NHANES III public use data files are linked with the common survey participant identification number (SEQN). Merging information from multiple NHANES III data files using this variable ensures that the appropriate information for each survey participant is linked correctly. o NHANES III public use data files do not have the same number of records on each file. The Household Questionnaire Files (divided into two files, Adult and Youth) contain more records than the Examination Data File because not everyone who was interviewed completed the examination. The Laboratory Data File contains data only for persons aged one year and older. The Individual Foods Data File based on the dietary recall has multiple records for each person rather than the one record per sample person contained in the other data files. o For each data file, SAS program code with standard variable names and labels is provided as separate text files on the CD-ROM that contains the data files. This SAS program code can be used to create a SAS data set from the data file. o Modifications were made to items in the questionnaires, laboratory, and examination components over the course of the survey; as a result, data may not be available for certain variables for the full six years. In addition, variables may differ by phase since some changes were implemented between phases. Users are encouraged to read the Notes sections of this document carefully for information about changes. o Extremely high and low values have been verified whenever possible, and numerous consistency checks have been performed. Nonetheless, users should examine the range and frequency of values before analyzing data. o Some data were not ready for release at the time of this publication due to continued processing of the data or analysis of laboratory specimens. A listing of those data are available in the general information section of each data file. o Confidential and administrative data are not being released to the public. Additionally, some variables have been recoded to help protect the confidentiality of the survey participants. For example, all age-related variables were recoded to 90+ years for persons who were 90 years of age and older. o Some variable names may differ from those used in the Phase 1 NHANES III Provisional Data Release and some variables included in the Phase 1 provisional release may not appear on these files. o Although the data files have been edited carefully, errors may be detected. Please notify NCHS staff (301-436-8500) of any errors in the data file or the documentation. Analytic Considerations o NHANES III (1988-94) was designed so that the survey's first three years, 1988-91, its last three years, 1991-94, and the entire six years were national probability samples. Analysts are encouraged to use all six years of survey results. o Sample weights are available for analyzing NHANES III data. One of the following three sample weights will be appropriate for nearly all analyses: interviewed sample final weight (WTPFQX6), examined sample final weight (WTPFEX6), and mobile examination center (MEC)- and home-examined sample final weight (WTPFHX6). Choosing which of these sample weights to use in any analysis depends on the variables being used. A good rule of thumb is to use "the least common denominator" approach. In this approach, the user checks the variables of interest. The variable that was collected on the smallest number of persons is the "least common denominator," and the sample weight that applies to that variable is the appropriate one to use for that analysis. For more detailed information, see the Analytic and Reporting Guidelines for NHANES III (U.S. DHHS, 1996). Referencing or Citing NHANES III Data o In publications, please acknowledge NCHS as the original data source. For instance, the reference for the NHANES III Laboratory Data File On this CD-ROM is: U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-1994, NHANES III Second Laboratory Data File (CD-ROM, Series 11, No. 2A). Hyattsville, MD.: Centers for Disease Control and Prevention, 1998. o Please place the acronym "NHANES III" in the titles or abstracts of journal articles and other publications in order to facilitate the retrieval of such materials in bibliographic searches. SURVEY DESCRIPTION The third National Health and Nutrition Examination Survey (NHANES III) was the seventh in a series of large health examination surveys conducted in the United States beginning in 1960. Three of these surveys, the National Health Examination Surveys (NHES), were conducted in the 1960's (NCHS, 1965; NCHS, 1967; NCHS, 1969). In 1970, an expanded nutrition component was added to provide data with which to assess nutritional status and dietary practices, and the name was changed to the National Health and Nutrition Examination Survey (Miller, 1973; Engel, 1978; McDowell, 1981). A special survey of Hispanic populations in the United States was conducted during 1982-1984 (NCHS, 1985). The general structure of the NHANES III sample design was similar to that of the previous NHANES. All of the surveys used complex, multi-stage, stratified, clustered samples of civilian, noninstitutionalized populations. NHANES III was the first NHANES without an upper age limit; in fact, the age range for the survey was two months and older. A home examination option was employed for the first time in order to obtain examination data for very young children and for elderly persons who were unable to visit the mobile examination center (MEC). The home examination included only a subset of the components used in the full MEC examination since it would have been difficult to collect some types of data in a home setting. A detailed description of design specifications and copies of the data collection forms can be found in the Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994 (NCHS, 1994; U.S. DHHS, 1996). NHANES III was conducted from October 1988 through October 1994 in two phases, each of which comprised a national probability sample. The first phase was conducted from October 18, 1988, through October 24, 1991, at 44 locations. The second phase was conducted from September 20, 1991, through October 15, 1994, at 45 different locations. In NHANES III, 39,695 persons were selected over the six years; of those, 33,994 (86%) were interviewed in their homes. All interviewed persons were invited to the MEC for a medical examination. Seventy-eight percent (30,818) of the selected persons were examined in the MEC, and an additional 493 persons were given a special, limited examination in their homes. Data collection began with a household interview. Several questionnaires were administered in the household: Household Screener Questionnaire, Family Questionnaire, Household Adult Questionnaire, and Household Youth Questionnaire. At the MEC, an examination was performed, and five automated questionnaires or interviews were administered: MEC Adult Questionnaire, MEC Youth Questionnaire, MEC Proxy Questionnaire, 24-Hour Dietary Recall, and Dietary Food Frequency (ages 12-16 years). The health examination component included a variety of tests and procedures. The examinee's age at the time of the interview and other factors determined which procedures were administered. Blood and urine specimens were obtained, and a number of tests and measurements were performed including body measurements, spirometry, fundus photography, x-rays, electrocardiography, allergy and glucose tolerance tests, and ultrasonography. Measurements were taken of bone density, hearing, and physical, cognitive, and central nervous system functions. A physician performed a limited standardized medical examination and a dentist performed a standardized dental examination. While some of the blood and urine analyses were performed in the MEC laboratory, most analyses were conducted elsewhere by contract laboratories. A home examination was conducted for those sample persons aged 2-11 months and aged 20 years or older who were unable to visit the mobile examination center. The home examination consisted of an abbreviated version of the tests and interviews performed in the MEC. Depending on age of the sample person, the components included body measurements, blood pressure, spirometry, venipuncture, physical function evaluation, and a questionnaire to inquire about infant feeding, selected health conditions, cognitive function, tobacco use, and reproductive history. SAMPLE DESIGN AND ANALYSIS GUIDELINES Sample Design The general structure of the NHANES III sample design is the same as that of the previous NHANES. Each of these surveys used a stratified, multi-stage probability design. The major design parameters of the two previous NHANES and the special Hispanic HANES, as well as NHANES III, have been previously summarized (Miller, 1973; McDowell, 1981; NCHS, 1985; NCHS, 1994). The NHANES III sample was designed to be self-weighting within a primary sampling unit (PSU) for subdomains (age, sex, and race-ethnic groups). While the sample was fairly close to self-weighting nationally for each of these subdomain groups, it was not representative of the total population, which includes institutionalized, non-civilian persons that were outside the scope of the survey. The NHANES III sample represented the total civilian, noninstitutionalized population, two months of age or over, in the 50 states and the District of Columbia of the United States. The first stage of the design consisted of selecting a sample of 81 PSU's that were mostly individual counties. In a few cases, adjacent counties were combined to keep PSU's above a minimum population size. The PSU's were stratified and selected with probability proportional to size (PPS). Thirteen large counties (strata) were chosen with certainty (probability of one). For operational reasons, these 13 certainty PSU's were divided into 21 survey locations. After the 13 certainty strata were designated, the remaining PSU's in the United States were grouped into 34 strata, and two PSU's were selected per stratum (68 survey locations). The selection was done with PPS and without replacement. The NHANES III sample therefore consists of 81 PSU's or 89 locations. The 89 locations were randomly divided into two groups, one for each phase. The first group consisted of 44 and the other of 45 locations. One set of PSU's was allocated to the first three-year survey period (1988-91) and the other set to the second three-year period (1991-94). Therefore, unbiased estimates (from the point of view of sample selection) of health and nutrition characteristics can be independently produced for both Phase 1 and Phase 2 as well as for both phases combined. For most of the sample, the second stage of the design consisted of area segments composed of city or suburban blocks, combinations of blocks, or other area segments in places where block statistics were not produced in the 1980 Census. In the first phase of NHANES III, the area segments were used only for a sample of persons who lived in housing units built before 1980. For units built in 1980 and later, the second stage consisted of sets of addresses selected from building permits issued in 1980 or later. These are referred to as "new construction segments." In the second phase, 1990 Census data and maps were used to define the area segments. Because the second phase followed within a few years of the 1990 Census, new construction did not account for a significant part of the sample, and the entire sample came from the area segments. The third stage of sample selection consisted of households and certain types of group quarters, such as dormitories. All households and eligible group quarters in the sample segments were listed, and a subsample was designated for screening to identify potential sample persons. The subsampling rates enabled production of a national, approximately equal-probability sample of households in most of the United States with higher rates for the geographic strata with high Mexican-American populations. Within each geographic stratum, there was a nearly equal-probability sample of households across all 89 stands. Persons within the sample of households or group quarters were the fourth stage of sample selection. All eligible members within a household were listed, and a subsample of individuals was selected based on sex, age, and race or ethnicity. The definitions of the sex, age, race or ethnic classes, subsampling rates, and designation of potential sample persons within screened households were developed to provide approximately self-weighting samples for each subdomain within geographic strata and at the same time to maximize the average number of sample persons per sample household. Previous NHANES indicated that this increased the overall participation rate. Although the exact sample sizes were not known until data collection was completed, estimates were made. Below is a summary of the sample sizes for the full six-year NHANES III at each stage of selection: Number of PSU's 81 Number of stands (survey locations) 89 Number of segments 2,144 Number of households screened 93,653 Number of households with sample persons 19,528 Number of designated sample persons 39,695 Number of interviewed sample persons 33,994 Number of MEC-examined sample persons 30,818 Number of home-examined sample persons 493 More detailed information on the sample design and weighting and estimation procedures for NHANES III can be found in the Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-94 (NCHS, 1994; U.S. DHHS, 1996) and in the Analytic and Reporting Guidelines: Third National Health and Nutrition Examination Survey (NHANES III), 1988-94 (U.S. DHHS, 1996). Analysis Guidelines Because of the complex survey design used in NHANES III, traditional methods of statistical analysis based on the assumption of a simple random sample are not applicable. Detailed descriptions of this issue and possible analytic methods for analyzing NHANES data have been described earlier (NCHS, 1985; Yetley, 1987; Landis, 1982; Delgado, 1990). Recent analytic and reporting guidelines that should be used for most NHANES III analyses and publications are contained in Analytic and Reporting Guidelines (U.S. DHHS, 1996). These recommendations differ slightly from those used by analysts for previous NHANES surveys. These suggested guidelines provide a framework to users for producing estimates that conform to the analytic design of the survey. All users are strongly urged to review these analytic and reporting guidelines before beginning any analyses of NHANES III data. It is important to remember that this set of statistical guidelines is not absolute. When conducting analyses, the analyst needs to use his/her subject matter knowledge (including methodological issues) as well as information about the survey design. The more one deviates from the original analytic categories defined in the sample design, the more important it is to evaluate the results carefully and to interpret the findings cautiously. In NHANES III, 89 survey locations were randomly divided into two sets or phases, the first consisting of 44 and the other of 45 locations. One set of PSU's was allocated to the first three-year survey period (1988-91) and the other set to the second three-year period (1991-94). Therefore, unbiased national estimates of health and nutrition characteristics can be independently produced for each phase as well as for both phases combined. Computation of national estimates from both phases combined (i.e., total NHANES III) is the preferred option; individual phase estimates may be highly variable. In addition, individual phase estimates are not statistically independent. It is also difficult to evaluate whether differences in individual phase estimates are real or due to methodological differences. That is, differences may be due to changes in sampling methods or data collection methodology over time. At this time, there is no valid statistical test for examining differences between Phase 1 and Phase 2. Therefore, although point estimates can be produced separately for each phase, no test is available to test whether those estimates are significantly different from each other. NHANES III is based on a complex, multi-stage probability sample design. Several aspects of the NHANES design must be taken into account in data analysis, including the sample weights and the complex survey design. Appropriate sample weights are needed to estimate prevalence, means, medians, and other statistics. Sample weights are used to produce correct population estimates because each sample person does not have the same probability of selection. The sample weights incorporate the differential probabilities of selection and include adjustments for noncoverage and nonresponse. A detailed discussion of nonresponse adjustments and issues related to survey coverage have been published (U.S. DHHS, 1996). With the large oversampling of young children, older persons, black persons, and Mexican-Americans in NHANES III, it is essential that the sample weights be used in all analyses. Otherwise, a misinterpretation of results is highly likely. Other aspects of the design that must be taken into account in data analyses are the strata and PSU pairings from the sample design. These pairings should be used to estimate variances and test for statistical significance. For weighted analyses, analysts can use special computer software packages that use an appropriate method for estimating variances for complex samples such as SUDAAN (Shah, 1995) and WesVarPC (Westat, 1996). Although initial exploratory analyses may be performed on unweighted data using standard statistical packages and assuming simple random sampling, final analyses should be done on weighted data using appropriate sample weights. A summary of the weighting methodology and the type of sample weights developed for NHANES III is included in Weighting and Estimation Methodology (U.S. DHHS, 1996). The purpose of weighting the sample data is to permit analysts to produce estimates of statistics that would have been obtained if the entire sampling frame (the United States) had been surveyed. Sample weights can be considered as measures of the number of persons the particular sample observation represents. Weighting takes into account several features of the survey: the specific probabilities of selection for the individual domains that were oversampled as well as nonresponse and differences between the sample and the total U.S. population. Differences between the sample and the population may arise due to sampling variability, differential undercoverage in the survey among demographic groups, and possibly other types of response errors, such as differential response rates or misclassification errors. Sample weighting in NHANES III was used to: 1. Compensate for differential probabilities of selection among subgroups (i.e., age-sex-race-ethnicity subdomains where persons living in different geographic strata were sampled at different rates); 2. Reduce biases arising from the fact that nonrespondents may be different from those who participate; 3. Bring sample data up to the dimensions of the target population totals; 4. Compensate, to the extent possible, for inadequacies in the sampling frame (resulting from omissions of some housing units in the listing of area segments, omissions of persons with no fixed address, etc.); and 5. To reduce variances in the estimation procedure by using auxiliary information that is known with a high degree of accuracy. In NHANES III, the sample weighting was carried out in three stages. The first stage involved the computation of weights to compensate for unequal probabilities of selection (objective 1, above). The second stage adjusted for nonresponse (objective 2). The third stage used poststratification of the sample weights to Census Bureau estimates of the U.S. population to accomplish the third, fourth, and fifth objectives simultaneously. In NHANES III, several types of sample weights (see the sample weights table that follows) were computed for the interviewed and examined sample and are included in the NHANES III data file. Also, sample weights were computed separately for Phase 1 (1988-91), Phase 2 (1991-94), and total NHANES III (1988-94) to facilitate analysis of items collected only in Phase 1, only in Phase 2, and over six years of the survey. Three sets of pseudo strata and PSU pairings are provided to use with SUDAAN in variance estimation. Since NHANES III is based on a complex, multi-stage sample design, appropriate sample weights should be used in analyses to produce national estimates of prevalence and associated variances while accounting for unequal probability of selection of sample persons. For example, the final interview weight, WTPFQX6, should be used for analysis of the items or questions from the family or household questionnaires, and the final MEC examination weight, WTPFEX6, should be used for analysis of the questionnaires and measurements administered in the MEC. Furthermore, for a combined analysis of measurements from the MEC examinations and associated medical history questions from the household interview, the final MEC examination weight, WTPFEX6, should be used. We recommend using SUDAAN (Shah, 1995) to estimate statistics of interest and the associated variance. However, one can also use other published methods for variance estimation. Application of SUDAAN and alternative methods, such as the average design effect approach, balance repeated replication (BRR) methods, or jackknife methods for variance estimation, are discussed in Weighting and Estimation Methodology (U.S. DHHS, 1996). Appropriate Uses of the NHANES III Sample Weights Final interview weight, WTPFQX6 Use only in conjunction with the sample interviewed at home and with items collected during the household interview. Final examination (MEC only) weight, WTPFEX6 Use only in conjunction with the MEC-examined sample and with interview and examination items collected at the MEC. Final MEC+home examination weight, WTPFHX6 Use only in conjunction with the MEC+home-examined sample and with items collected at both the MEC and home. Final allergy weight, WTPFALG6 Use only in conjunction with the allergy subsample and with items collected as part of the allergy component of the exam. Final CNS weight, WTPFCNS6 Use only in conjunction with the CNS subsample and with items collected as part of the CNS component of the exam. Final morning examination (MEC only) subsample weight, WTPFSD6 Use only in conjunction with the MEC-examined persons assigned to the morning subsample and only with items collected in the MEC exam. Final afternoon/evening examination (MEC only) subsample weight, WTPFMD6 Use only in conjunction with the MEC-examined persons assigned to the afternoon/evening subsample and only with items collected in the MEC exam. Final morning examination (MEC+home) subsample weight, WTPFHSD6 Use only in conjunction with the MEC- and home-examined persons assigned to the morning subsample and with items collected during the MEC and home examinations. Final afternoon/evening examination (MEC+home) weight, WTPFHMD6 Use only in conjunction with the MEC- and home-examined persons assigned to the afternoon/evening subsample and with items collected during the MEC and home examinations. DATA PREPARATION AND PROCESSING PROCEDURES Automated data collection procedures for the survey were introduced in NHANES III. In the mobile examination centers, data for the interview and examination components were recorded directly onto a computerized data collection form. With the exception of a few independently automated systems, the system was centrally integrated. This operation allowed for ongoing monitoring of much of the data. Before the introduction of the computer-assisted personal interview (CAPI), the household questionnaire data were reviewed manually by field editors and interviewers. CAPI (1992-1994 only) questionnaires featured built-in edits to prevent entering inconsistencies and out-of-range responses. The multi-level data collection and quality control systems are discussed in detail in the Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994 (NCHS, 1994; U.S. DHHS, 1996). All interview, laboratory, and examination data were sent to NCHS for final processing. Guidelines were developed that provided standards for naming variables, filling missing values and coding conventional responses, handling missing records, and standardizing two-part quantity/unit questionnaire variables. NCHS staff, assisted by contract staff, developed data editing specifications that checked data sets for valid codes, ranges, and skip pattern consistencies and examined the consistency of values between interrelated variables. Comments, collected in both interviews and examination components, were reviewed and recoded when possible. Responses to "Other" and "Specify" were recoded either to existing code categories or to new categories. The documentation for each data set includes notes for those variables that have been recoded and standardized and for those variables that differ significantly from what appears in the original data collection instrument. While the data have undergone many quality control and editing procedures, there still may be values that appear extreme or illogical. Values that varied considerably from what was expected were examined by analysts who checked for comments or other responses that might help to clarify unusual values. Generally, values were retained unless they could not possibly be true, in which case they were changed to "Blank but applicable." Therefore, the user must review each data set for extreme or inconsistent values and determine the status of each value for analysis. Several editing conventions were used in the creation of final analytic data sets: 1. Standardized variables were created to replace all two-part quantity/unit questions using standard conversion factors. Standardized variables have the same name as the variable of the two-part question with an "S" suffix. For instance, MAPF18S (Months received WIC benefits) in the MEC Adult Questionnaire was created from the two-part response option to question F18, "How long did you receive benefits from the WIC program?," using the conversion factor 12 months per year. 2. Recoded variables were created by combining responses from two or more like variables, or by collapsing responses to create a summary variable for the purpose of confidentiality. Recoded variables have the original variable name with an R suffix. For example, place of birth variable (HFA6X) in the Family Questionnaire was collapsed to a three level response category (U.S., Mexico, Other) and renamed HFA6XR. Generally, only the recoded variable has been included in the data file. 3. Fill values, a series of one or more digits, were used to represent certain specific conditions or responses. Below is a list of the fill values that were employed. Some of the fill values pertain only to questionnaire data, although 8-fill and blank-fill values are found in all data sets. Other fill values, not included in this list, are used to represent component-specific conditions. 6-fills = Varies/varied. (Questionnaires only) 7-fills = Fewer than the smallest number that could be reported within the question structure (e.g., fewer than one cigarette per day). (Questionnaires only) 8-fills = Blank but applicable/cannot be determined. This means that a respondent was eligible to receive the question, test, or component but did not because of refusal, lack of time, lack of staff, loss of data, broken vial, language barrier, unreliability, or other similar reasons. 9-fills = Don't know. This fill was used only when a respondent did not know the response to a question and said, "I don't know." (Questionnaires only) Blank fills = Inapplicable. If a respondent was not eligible for a questionnaire, test, or component because of age, gender, or specific reason, the variable was blank-filled. In the questionnaire, if a respondent was not asked a question because of a skip-pattern, variables corresponding to the question were blank-filled. For examination or laboratory components, if a person was excluded by a defined protocol (e.g., screening exclusion questions) and these criteria are included in the data set, then the corresponding variables were blank-filled for that person. For home examinees, variables for examination components and blood tests not performed as part of the home examination protocol were blank-filled. 4. For variables describing discrete data, codes of zero (0) were used to mean "none," "never," or the equivalent. Value labels for which "0" is used include: "has not had," "never regularly," "still taking," or "never stopped using." Unless otherwise labeled, for variables containing continuous data, "zero" means "zero. 5. Where there are logical skip patterns in the flow of the questionnaire or examination component, the skip was indicated by placing the variable label of the skip destination in parentheses as part of the value label of the response generating the skip. For example, in the Physical Function Evaluation, the variable PFPWC (in wheelchair) has a value label, "2 No (PFPSCOOT)" that means that the next item for persons not in a wheelchair would be represented by the variable, PFPSCOOT. Variable Nomenclature A unique name was assigned to every NHANES III variable using a standard convention. By following this naming convention, the origin of each variable is clear, and there is no chance of overlaying similar variables across multiple components. Variables range in length from three to eight characters. The first two variable characters represent the topic (e.g., analyte, questionnaire instrument, examination component) and are listed below alphabetically by topic. For questionnaires administered in the household, the remainder of the variable name following the first two characters indicates the question section and number. For example, data for the response to the Household Adult Questionnaire question B1 are contained in the variable HAB1. For most laboratory and examination variables, as well as some other variables, a "P" in the third position refers to "primary" and the remainder of the variable name is a brief description of the item. For instance, in the Laboratory Data File, information on the length of time the person fasted before the first blood draw is contained in the variable PHPFAST. The variable PHPFAST was derived as follows: characters 1-2 (PH) refer to "phlebotomy," character 3 (P) refers to "primary," characters 4-8 (FAST) refer to an abbreviation for "fasting." CODE TOPIC AT Alanine aminotransferase (from biochemistry profile) AM Albumin (from biochemistry profile) AP Alkaline phosphatase (from biochemistry profile) AL Allergy skin test AC Alpha carotene AN Anisocytosis TM Antimicrosomal antibodies TA Antithyroglobulin antibodies AA Apolipoprotein (AI) AB Apolipoprotein (B) AS Aspartate aminotransferase (from biochemistry profile) LA Atypical lymphocyte AU Audiometry BA Band BO Basophil BS Basophilic stippling BC Beta carotene BX Beta cryptoxanthin BL Blast BU Blood urea nitrogen (BUN) (from biochemistry profile) BM Body measurements BD Bone densitometry C1 C-peptide (first venipuncture) C2 C-peptide (second venipuncture) CR C-reactive protein UD Cadmium CN Central nervous system function evaluation CL Chloride (from biochemistry profile) CO Cotinine CE Creatinine (serum)(from biochemistry profile) UR Creatinine (urine) CODE TOPIC DM Demographic DE Dental examination MQ Diagnostic interview schedule DR Dietary recall (total nutrient intakes) EO Eosinophil EP Erythrocyte protoporphyrin FR Ferritin FB Fibrinogen RB Folate (RBC) FO Folate (serum) FH Follicle stimulating hormone (FSH) FP Fundus photography GG Gamma glutamyl transferase (GGT) (from biochemistry profile) GU Gallbladder ultrasonography GB Globulin (from biochemistry profile) G1 Glucose (first venipuncture) G2 Glucose (second venipuncture) SG Glucose (from biochemistry profile) GH Glycated hemoglobin GR Granulocyte C3 HCO3 (Bicarbonate)(from biochemistry profile) HD HDL cholesterol HP Helicobacter pylori antibody HT Hematocrit HG Hemoglobin AH Hepatitis A antibody (HAV) HB Hepatitis B core antibody (anti-HBc) SS Hepatitis B surface antibody (anti-HBs) SA Hepatitis B surface antigen (HBsAg) HC Hepatitis C antibody (HCV) DH Hepatitis D antibody (HDV) H1 Herpes 1 antibody H2 Herpes 2 antibody HX Home examination (general) HO Homocysteine HF Household family questionnaire HA Household adult questionnaire HQ Household questionnaire variables (composite) HS Household screener questionnaire HY Household youth questionnaire HZ Hypochromia I1 Insulin (first venipuncture) I2 Insulin (second venipuncture) UI Iodine (urine) FE Iron SF Iron (from biochemistry profile) LD Lactate dehydrogenase (from biochemistry profile) L1 Latex antibody LC LDL cholesterol (calculated) PB Lead LP Lipoprotein (a) LH Luteinizing hormone CODE TOPIC LU Lutein/zeaxanthin LY Lycopene LM Lymphocyte MR Macrocyte MC Mean cell hemoglobin (MCH) MH Mean cell hemoglobin concentration (MCHC) MV Mean cell volume (MCV) PV Mean platelet volume MA MEC adult questionnaire MX MEC examination (general) FF Dietary food frequency (ages 12-16 years) MP MEC proxy questionnaire MY MEC youth questionnaire ME Metamyelocyte MI Microcyte MO Monocyte MN Mononuclear cell ML Myelocyte IC Normalized calcium (derived from ionized calcium) OS Osmolality (from biochemistry profile) PH Phlebotomy data collected in MEC (e.g., questions) PS Phosphorus (from biochemistry profile) PF Physical function evaluation PE Physician's examination PL Platelet DW Platelet distribution width PK Poikilocytosis PO Polychromatophilia SK Potassium (from biochemistry profile) PR Promyelocyte RC Red blood cell count (RBC) RW Red cell distribution width (RDW) RE Retinyl esters RF Rheumatoid factor antibody RU Rubella antibody WT Sample weights SE Selenium SI Sickle cell NA Sodium (from biochemistry profile) SH Spherocyte SP Spirometry SD Survey design TT Target cell TE Tetanus TH Thyroid Stimulating Hormone (TSH) T4 Thyroxine TB Total bilirubin (from biochemistry profile) CA Total calcium SC Total calcium (from biochemistry profile) TC Total cholesterol CH Total cholesterol (from biochemistry profile) TI Total iron binding capacity (TIBC) TP Total protein (from biochemistry profile) TX Toxic granulation CODE TOPIC TO Toxoplasmosis antibody PX Transferrin saturation TG Triglycerides TR Triglycerides (from biochemistry profile) TY Tympanometry UA Uric acid (from biochemistry profile) UB Urinary albumin VU Vacuolated cells VR Varicella antibody VA Vitamin A VB Vitamin B12 VC Vitamin C VD Vitamin D VE Vitamin E WC White blood cell count (WBC) WW WISC/WRAT cognitive test GENERAL REFERENCES Delgado JL, Johnson CL, Roy I, Trevino FM. Hispanic Health and Nutrition Examination Survey: methodological considerations. Amer J Pub Health 80(suppl.):6-10. 1990. Engel A, Murphy RS, Maurer K, Collins E. Plan and operation of the HANES I Augmentation Survey of Adults 25-74 Years, United States, 1974-75. National Center for Health Statistics. Vital Health Stat 1(14). 1978. Freeman DH, Freeman JL, Brock DB, Koch GG. Strategies in the multivariate analysis of data from complex surveys II: an application to the United States National Health Interview Survey. Int Stat Rev 40(3):317-30. 1976. Khare M, Mohadjer LK, Ezzati-Rice TM, Waksberg J. An evaluation of nonresponse bias in NHANES III (1988-91). 1994 Proceedings of the Survey Research Methods section of the American Statistical Association. 1994. Landis JR, Lepkowski JM, Eklund SA, Stehouwer SA. A statistical methodology for analyzing data from a complex survey, the first National Health and Nutrition Examination Survey. National Center for Health Statistics. Vital Health Stat 2(92). 1982. McDowell A, Engel A, Massey JT, Maurer K. Plan and operation of the second National Health and Nutrition Examination Survey, 1976-80. National Center for Health Statistics. Vital Health Stat 1(15). 1981. Miller HW. Plan and operation of the Health and Nutrition Examination Survey, United States, 1971-1973. National Center for Health Statistics. Vital Health Stat 1(10a) and (10b). 1973. National Center for Health Statistics. Plan and initial program of the Health Examination Survey. Vital Health Stat 1(4). 1965. National Center for Health Statistics. Plan and operation of a health examination survey of U.S. youths 12-17 years of age. Vital Health Stat 1(8). 1969. National Center for Health Statistics. Plan and operation of the Hispanic Health and Nutrition Examination Survey, 1982-84. Vital Health Stat 1(19). 1985. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1(32). 1994. National Center for Health Statistics. Plan, operation, and response results of a program of children's examinations. Vital Health Stat 1(5). 1967. Shah BV, Barnwell BG, Bieler GS. SUDAAN User's Manual: Software for Analysis of Correlated Data. Research Triangle Park, NC: Research Triangle Institute. Release 6.04. 1995. Skinner CJ. Aggregated analysis: standard errors and significance tests. In: Skinner CJ, Holt D, Smith TMF, eds. Analysis of complex surveys. New York: John Wiley and Sons, Inc. 1989. U.S. Department of Health and Human Services (DHHS). National Center for Health Statistics. NHANES III reference manuals and reports (CD-ROM). Hyattsville, MD: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service (NTIS), Springfield, VA. Acrobat .PDF format; includes access software: Adobe Systems, Inc. Acrobat Reader 2.1. Westat, Inc. A User's Guide to WesVarPC. Rockville, MD. Westat, Inc. 1996. Yetley E, Johnson C. Nutritional applications of the Health and Nutrition Examination Surveys (HANES). Annu Rev Nutr 7:441-63. 1987. Household Questionnaire: Prescription Medicines General Information During the household interview respondents were asked a series of questions about prescription medicines used during in the past month. A proxy, usually a child's parent or guardian, provided this information for children 2 months to 16 years of age. If respondents or proxy respondents reported taking a prescription medicine, they were asked the number of prescription medicines they took. For each medication reported, the interviewer asked to see the medication container in order to record the name of the product. If the container was not available, the interviewer probed for this information. Respondents or proxies were also asked to describe the health problem for which they took the medicine, and how long they had been taking the medicine. Analysts should be aware, however, that there were respondents or proxies who reported taking prescription medicines, but did not answer some or all of the remaining questions about the prescription medicines. In other cases respondents or proxies reported a health problem and/or duration they took a medication, but did not know the name of the medication or NCHS staff could not identify the name. In both cases, the missing fields are coded as either "blank but applicable" (8-fill) or "don't know" (9-fill), whichever was applicable. Some prescription medicines originally reported in the supplements, antacid, or non-prescription drug sections of the questionnaire were moved to the prescription medicine section of the questionnaire. Some prescribed vitamin and/or mineral supplements, originally reported in the prescription medicines section, could be considered both a drug or a supplement (e.g., calciferol, niacin, calcitriol, and potassium). These products were copied to the dietary supplements section. In general, non-prescription medications that were reported in the prescription drug section of the household adult questionnaire were moved to the non-prescription medications section (the expanded non-prescription pain relief medications section to be described later), but those medications reported on the household youth questionnaire were deleted since a non-prescription medications section was not included on the youth questionnaire. However, for both the household youth and adult questionnaires if a particular medication reported in the prescription medication section of the questionnaire was available in both prescription and non-prescription strengths (e.g., ibuprofen), the staff assumed it was a prescription medication and left it in this section. On the adult questionnaire, aspirin was moved to the non-prescription medications sections unless the strength or brand name reported was only available by prescription (e.g., "Zorprin"). Also on the household adult questionnaire, prescription antacids were left in this section, but over-the-counter antacids were moved to the antacid section unless, at the time of the survey, the antacid was only available by prescription (e.g., "Zantac"). Each prescription medicine name reported in the survey was located in the Physicians' GenRx, and assigned the standard generic name and 4-digit generic code for that product. However, for five prescription medications a generic name or code did not exist. The NCHS staff created product codes for these medicines. See the notes associated with this variable in the data file layout for a detailed discussion of the prescription medication product code. A list of the standardized generic prescription medication names and their associated product codes can be found in Appendix 1. In some cases it may appear as though respondents reported the same prescription medicine more than once. That is, the same generic prescription medicine name and product code may be listed more than once. There are a number of reasons for these duplications. Respondents may have reported different brand name medicines which had the same generic name (e.g., "Adalat" vs. "Procardia"), or the medicines may have been different forms (e.g., tablet vs. patch), strengths (e.g., 20 mg vs. 30 mg), or dosages (e.g., once a day vs. twice a day) of the same product. Based on the information collected when respondents reported different brand names of the same generic product it was difficult to determine if these were duplicate listings or the individuals had taken more than one product in the month. Also, since descriptive information on the form, strength, and dosage of prescription medicines was not collected it was difficult to determine if these were reasons for the duplications. Hence, most of the duplicates have been left in the file. Up to three drug class codes (i.e., primary, secondary, and tertiary) were assigned to each prescription medication that a respondent reported. These 4-digit codes came from the National Drug Code Directory prepared by the Product Information Management Branch of the Food and Drug Administration. See Appendix 2 for a listing of the drug class codes and descriptions. Drug class codes were assigned for each medication, primarily based on the medication's action or response and, secondarily, on the health problem for which the respondent reported taking the medication. For example, all cardiovascular drugs that were beta-adrenergic blocking agents were assigned the drug class code for "Beta blockers" (512). Additional drug class codes were assigned based on the reason the respondent reported for taking the medication, for example, "Antiarrhythmics" (502) or "Antihypertensives" (506). Another example is the drug "Diazepam". The primary drug class code for "Diazepam" is sedative or hypnotic (626). If the respondent reported any of the following reasons for taking the drug, the drug class fields were also coded with these reasons: anxiety (627), muscle spasms (1373), or convulsive disorder (1374). If the reason the respondent gave did not relate to any of the actions of the drug, then only the medication-specific class code was assigned. There are instances where the prescription medication product code and standard generic name are coded as "blank but applicable" (8-fill), but there is a valid primary drug class code. In these cases, the medication name and/or health condition that the respondent reported provided sufficient information in order to assign a drug class code. ICD-9-CM codes were used to classify the health problem respondents gave for taking the prescription medicine. In general, the health problems were coded to the fourth digit ICD-9-CM level of specificity, but in some cases the highest level of specificity was only three digits and in other cases the level of specificity was five digits. See the notes associated with this variable in the data file layout for a detailed discussion of the ICD-9-CM codes. See Appendix 3 for a listing of the ICD-9-CM codes and descriptions. As described earlier there were respondents who reported taking a prescription medicine but did not give a reason why they took the medicine. In these instances the ICD-9 codes are coded as "blank but applicable" (8-fill) or "don't know" (9-fill). On the other hand, there were respondents who reported a health problem but did not report the medication they were taking or NCHS staff could not identify it. In these cases the prescription medication product code, and sometimes the drug class codes, are coded as "blank but applicable" (8-fill) or "don't know" (9-fill), but there is an ICD-9 code listed. For each prescription medicine reported, respondents were also asked how long they had been taking the medicine. See the notes associated with this variable in the data file layout for a detailed discussion of this variable. When medicines were moved from the dietary supplements section to the prescription medicine section some of the categories for duration of use did not correspond. A response of "less than one month" in the supplements section was changed to "blank but applicable" (8-fill) in prescription medicine section. NHANES III Prescription Medicines Data File Index ------------------------------------------------------------------------ Variable Description Name Positions ------------------------------------------------------------------------ Respondent identification number ............ SEQN 1-5 Prescription medicine product code .......... HQRXCODE 6-10 Taken prescriptn medicines in past month .... HQKX1B 11 Number of prescription medicines taken ...... HQKX2B 12-13 Primary drug class code ..................... HQKX9D 14-17 Secondary drug class code ................... HQKX9E 18-21 Tertiary drug class code .................... HQKX9F 22-25 ICD-9-CM code ............................... HQKX11A 26-31 For how long been taking (days) ............. HQKX12S 32-36 NHANES III Prescription Medicines Data File ------------------------------------------------------------------------ FILENAME=PUPREMED VERSION 1.0 N=27774 ------------------------------------------------------------------------ HOUSEHOLD QUESTIONNAIRE ------------------------------------------------------------------------ PRESCRIPTION MEDICINES ------------------------------------------------------------------------ Positions Item description SAS name Counts and code Notes ------------------------------------------------------------------------ 1-5 Sample person identification number SEQN 27774 00009-53621 6-10 Prescription medication See note HQRXCODE product code 25288 00002-07503 2159 88888 Blank but applicable 327 99999 Don't know 11 Have you taken or used any medicines for See note HQKX1B which a doctor's or dentist's prescrip- tion is needed, in the past month? This includes any products which cannot be obtained without a doctor's or dentist's prescription. Include those medicines you may have already mentioned. DO NOT INCLUDE PRESCRIPTION VITAMINS WHICH SHOULD BE RECORDED AT HAX1A. 26759 1 Yes 1015 8 Blank but applicable 12-13 Number of prescription medicines See note HQKX2B reported 26759 01-16 1015 88 Blank but applicable 14-17 Primary drug class code See note HQKX9D 25809 0100-2100 1638 8888 Blank but applicable 327 9999 Don't know NHANES III Prescription Medicines Data File ------------------------------------------------------------------------ HOUSEHOLD QUESTIONNAIRE ------------------------------------------------------------------------ PRESCRIPTION MEDICINES ------------------------------------------------------------------------ Positions Item description SAS name Counts and code Notes ------------------------------------------------------------------------ 18-21 Secondary drug class code See note HQKX9E 5065 0121-1900 22382 8888 Blank but applicable 327 9999 Don't know 22-25 Tertiary drug class code See note HQKX9F 192 0348-1271 27255 8888 Blank but applicable 327 9999 Don't know 26-31 ICD-9-CM code See note HQKX11A 25803 V01.1-999.3 1449 888888 Blank but applicable 522 999999 Don't know 32-36 For how long have you been taking or See note HQKX12S using (MEDICINE)? (days) 26008 00001-23360 1267 88888 Blank but applicable 499 99999 Don't know Notes: HQKX1B: Have you taken or used any prescription medicines in the past month? This variable was the lead-in question for a series of questions on prescription medicine use, and includes prescription medicines reported in this section as well as prescription medicines moved from the supplements, antacid, or non-prescription drug sections of the questionnaire. HQKX2B: Number of prescription medicines reported This variable represents the total number of different prescription medicines reported by the respondent. The count includes all prescription medicines including those moved from other sections to the prescription medicines section. HQRXCODE: Prescription medication product code Each prescription medicine name reported in the survey was located in the Physicians' GenRx, and assigned the standard generic name and 4-digit generic code for that product. The prescription medication product code NCHS staff used for this variable is the same as the 4-digit generic code listed for each drug in this book. There were no generic names or codes for five prescription medications. These were: Insulin (7000); Kaolin, Paregoric, Pectin (7500); Hydrocodone Bitartrate (7501); Tiaprofenic Acid (7502); Diphenoxylate Hydrochloride (7503). The number in parentheses is the product code number NCHS staff assigned to these drugs. The generic name and product code were coded as "blank but applicable" (8-fill) when the name reported did not refer to a specific product (e.g., "cold tablet", "estrogen", "hormones", "antibiotic", or "water pill"), or when the name could not be identified. The name and code were coded as "don't know" (9-fill) when the respondent did not know the name of the product. A list of the standardized generic prescription medication names and their associated product codes can be found in Appendix 1. HQKX9D: Primary drug class code This variable contains the first of 3 possible drug class codes assigned to the prescription medication that was reported. These 4-digit codes came from the National Drug Code Directory. Drug class codes were assigned for each medication, primarily based on the medication's action or response and, secondarily, on the health problem for which the respondent reported taking the medication. This variable most likely contains the medication response. See Appendix 2 for a listing of the drug class codes and descriptions. HQKX9E: Secondary drug class code This variable contains the second drug class code for each prescription medication that was reported. Drug class codes were assigned for each medication, primarily based on the medication's action or response and, secondarily, on the health problem for which the respondent reported taking the medication. If this variable contains a drug class code it may be either based on the medication's action or the health problem for which the respondent reported taking the medication. See Appendix 2 for a listing of the drug class codes and descriptions. HQKX9F: Tertiary drug class code This variable contains the third drug class code for each prescription medication that was reported. Drug class codes were assigned for each medication, primarily based on the medication's action or response and, secondarily, on the health problem for which the respondent reported taking the medication. If this variable contains a drug class code it may be either based on the medication's action or the health problem for which the respondent reported taking the medication. See Appendix 2 for a listing of the drug class codes and descriptions. HQKX11A: ICD-9-CM code ICD-9-CM codes were used to classify the health problem respondents reported as the reason for taking the prescription medicine. In general, the health problems were coded to the fourth digit ICD-9-CM level of specificity. However, in some cases the highest level of specificity for the ICD-9-CM code was only three digits and in other cases the level of specificity was five digits. When no appropriate code was available in the Classification of Diseases and Injuries ICD-9-CM codes, health problems were coded using V Codes - Supplementary Classification of Factors Influencing Health Status and Contact with Health Services. Some examples of these health problems were birth control, hormone replacement, and treatment to prevent infections. See Appendix 3 for a listing of the ICD-9-CM codes and descriptions. HQKX12S: For how long have you been taking this medicine? (days) This variable was created from the two-part (number and unit) question K12/X12, and indicates how long the respondent reported taking each prescription medicine. All responses were recoded to days. The conversion factors used were 7 days/week, 30.4 days/month and 365 days/year. Appendix 1 Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0002 ACEBUTOLOL HYDROCHLORIDE 0020 ACETAMINOPHEN; BUTALBITAL 0021 ACETAMINOPHEN; BUTALBITAL; CAFFEINE 0022 ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE 0046 ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0048 ACETAMINOPHEN; CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE 0050 ACETAMINOPHEN; CHLORZOXAZONE 0051 ACETAMINOPHEN; CODEINE PHOSPHATE 0064 ACETAMINOPHEN; DICHLORALPHENAZONE; ISOMETHEPTENE MUCATE 0070 ACETAMINOPHEN; HYDROCODONE BITARTRATE 0072 ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE 0074 ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE 0081 ACETAMINOPHEN; PROPOXYPHENE HYDROCHLORIDE 0082 ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE 0084 ACETAMINOPHEN; SALICYLAMIDE 0086 ACETAZOLAMIDE 0087 ACETIC ACID 0088 ACETIC ACID; HYDROCORTISONE 0092 ACETOHEXAMIDE 0105 ACYCLOVIR 0115 ALBUTEROL 0116 ALCLOMETASONE DIPROPIONATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0133 ALLOPURINOL 0140 ALPRAZOLAM 0154 ALUMINUM CHLORIDE HEXAHYDRATE 0174 AMANTADINE HYDROCHLORIDE 0176 AMCINONIDE 0179 AMILORIDE HYDROCHLORIDE 0180 AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE 0207 AMINOPHYLLINE 0212 AMIODARONE HYDROCHLORIDE 0213 AMITRIPTYLINE HYDROCHLORIDE 0214 AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE 0215 AMITRIPTYLINE HYDROCHLORIDE; PERPHENAZINE 0230 AMOXAPINE 0231 AMOXICILLIN 0232 AMOXICILLIN; CLAVULANATE POTASSIUM 0239 AMPICILLIN/AMPICILLIN TRIHYDRATE 0244 AMYLASE; CELLULASE; LIPASE; PROTEASE 0254 ANTAZOLINE PHOSPHATE; NAPHAZOLINE HYDROCHLORIDE 0255 ANTHRALIN 0260 ANTIHEMOPHILIC FACTOR, HUMAN 0263 ANTIPYRINE; BENZOCAINE 0264 ANTIPYRINE; BENZOCAINE; PHENYLEPHRINE HYDROCHLORIDE 0276 APRACLONIDINE HYDROCHLORIDE 0299 ASPIRIN Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0302 ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE 0304 ASPIRIN; BUTALBITAL; CAFFEINE 0306 ASPIRIN; CAFFEINE; DIHYDROCODEINE BITARTRATE 0310 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE 0311 ASPIRIN; CAFFEINE; PROPOXYPHENE HYDROCHLORIDE 0314 ASPIRIN; CARISOPRODOL 0315 ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE 0317 ASPIRIN; CODEINE PHOSPHATE 0320 ASPIRIN; MEPROBAMATE 0321 ASPIRIN; METHOCARBAMOL 0322 ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE 0332 ASTEMIZOLE 0333 ATENOLOL 0334 ATENOLOL; CHLORTHALIDONE 0336 ATROPINE SULFATE 0338 ATROPINE SULFATE; DIFENOXIN HYDROCHLORIDE 0339 ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE 0340 ATROPINE SULFATE; BENZOIC ACID; HYOSCYAMINE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE 0347 AURANOFIN 0349 AZATADINE MALEATE 0350 AZATADINE MALEATE; PSEUDOEPHEDRINE SULFATE 0351 AZATHIOPRINE 0356 BACITRACIN Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0357 BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 0358 BACITRACIN ZINC; POLYMYXIN B SULFATE 0361 BACLOFEN 0376 BECLOMETHASONE DIPROPIONATE 0380 BELLADONNA; CAFFEINE; ERGOTAMINE; PENTOBARBITAL 0382 BELLADONNA 0383 BELLADONNA ALKALOIDS; PHENOBARBITAL 0389 BELLADONNA; ENZYME(S); PHENOBARBITAL 0391 BELLADONNA; KAOLIN; PAREGORIC; PECTIN 0403 BENDROFLUMETHIAZIDE; NADOLOL 0417 BENZOCAINE 0446 BENZONATATE 0447 BENZOYL PEROXIDE 0448 BENZOYL PEROXIDE; ERYTHROMYCIN 0455 BENZTROPINE MESYLATE 0462 BETAMETHASONE 0465 BETAMETHASONE DIPROPIONATE 0466 BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE 0468 BETAMETHASONE VALERATE 0469 BETAXOLOL HYDROCHLORIDE 0470 BETHANECHOL CHLORIDE 0476 BILE SALTS; PANCREATIN; PEPSIN 0505 BITOLTEROL MESYLATE 0527 BROMOCRIPTINE MESYLATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0528 BROMODIPHENHYDRAMINE HYDROCHLORIDE; CODEINE PHOSPHATE 0529 BROMPHENIRAMINE MALEATE 0530 BROMPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0531 BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE 0532 BROMPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0533 BROMPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE 0534 BROMPHENIRAMINE; DEXTROMETHORPHAN; PHENYLPROPANOLAMINE 0538 BROMPHENIRAMINE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLTOLOXAMINE 0544 BUMETANIDE 0550 BUPROPION HYDROCHLORIDE 0551 BUSPIRONE HYDROCHLORIDE 0557 BUTABARBITAL SODIUM 0574 CAFFEINE; ERGOTAMINE TARTRATE 0585 CALCITONIN, SALMON 0586 CALCITRIOL 0607 CALCIUM IODIDE; CODEINE PHOSPHATE 0642 CAPTOPRIL 0643 CAPTOPRIL; HYDROCHLOROTHIAZIDE 0644 CARAMIPHEN; PHENYLPROPANOLAMINE 0645 CARBACHOL 0646 CARBAMAZEPINE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0652 CARBETAPENTANE TANNATE; CHLORPHENIRAMINE TANNATE; EPHEDRINE TANNATE; PHENYLEPHRINE HYDROCHLORIDE 0653 CARBIDOPA; LEVODOPA 0655 CARBINOXAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE 0656 CARBINOXAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE 0664 CARISOPRODOL 0666 CARTEOLOL HYDROCHLORIDE 0680 CEFACLOR 0681 CEFADROXIL 0684 CEFIXIME 0687 CEFOPERAZONE SODIUM 0694 CEFTRIAXONE SODIUM 0695 CEFUROXIME AXETIL 0698 CEPHALEXIN 0699 CEPHALEXIN HYDROCHLORIDE 0702 CEPHRADINE 0726 CHLORDIAZEPOXIDE HYDROCHLORIDE 0727 CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE 0728 CHLORDIAZEPOXIDE; ESTROGENS, ESTERIFIED 0729 CHLORHEXIDINE GLUCONATE 0738 CHLOROQUINE PHOSPHATE 0739 CHLOROTHIAZIDE 0740 CHLOROTHIAZIDE; METHYLDOPA 0741 CHLOROTHIAZIDE; RESERPINE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0743 CHLOROXINE 0749 CHLORPHENIRAMINE MALEATE; HYDROCODONE; PHENYLEPHRINE HYDROCHLORIDE 0751 CHLORPHENIRAMINE MALEATE 0753 CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE 0754 CHLORPHENIRAMINE MALEATE; EPINEPHRINE 0755 CHLORPHENIRAMINE MALEATE; METHSCOPOLAMINE NITRATE; PHENYLEPHRINE HYDROCHLORIDE 0756 CHLORPHENIRAMINE MALEATE; PHENINDAMINE TARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0757 CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLTOLOXAMINE CITRATE 0758 CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0759 CHLORPHENIRAMINE MALEATE; PSEUDOEPHEDRINE HYDROCHLORIDE 0760 CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX 0761 CHLORPHENIRAMINE TANNATE; PHENYLEPHRINE TANNATE; PYRILAMINE TANNATE 0767 CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; POTASSIUM IODIDE 0775 CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE 0776 BECLOMETHASONE DIPROPIONATE 0790 CHLORPHENIRAMINE MALEATE; HYDROCODONE; PSEUDOEPHEDRINE 0792 CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLPROPANOLAMINE; PHENYLTOLOXAMINE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0793 CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLPROPANOLAMINE; PYRILAMINE 0797 CHLORPROMAZINE HYDROCHLORIDE 0798 CHLORPROPAMIDE 0801 CHLORTHALIDONE 0802 CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE 0803 CHLORTHALIDONE; RESERPINE 0804 CHLORZOXAZONE 0808 CHOLESTYRAMINE 0811 CHOLINE MAGNESIUM TRISALICYLATE 0817 CICLOPIROX OLAMINE 0820 CIMETIDINE 0823 CIPROFLOXACIN HYDROCHLORIDE 0830 CITRIC ACID; SODIUM CITRATE 0835 CLEMASTINE FUMARATE 0836 CLEMASTINE FUMARATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 0838 CLINDAMYCIN HYDROCHLORIDE 0839 CLOBETASOL PROPIONATE 0842 CLOFIBRATE 0843 CLOMIPHENE CITRATE 0845 CLONAZEPAM 0846 CLONIDINE HYDROCHLORIDE 0847 CLORAZEPATE DIPOTASSIUM 0848 CLOTRIMAZOLE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0850 CLOXACILLIN SODIUM 0851 CLOZAPINE 0870 CODEINE PHOSPHATE 0873 CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE 0874 CODEINE PHOSPHATE; IODINATED GLYCEROL 0875 CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE 0876 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE 0878 CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE 0881 CODEINE PHOSPHATE; GUAIFENESIN 0883 CODEINE PHOSPHATE; GUAIFENESIN; PHENYLPROPANOLAMINE 0890 COLCHICINE 0891 COLCHICINE; PROBENECID 0892 COLESTIPOL HYDROCHLORIDE 0894 COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE 0907 CORTISONE ACETATE 0916 CROMOLYN SODIUM 0924 CYCLANDELATE 0926 CYCLOBENZAPRINE HYDROCHLORIDE 0930 CYCLOPHOSPHAMIDE 0932 CYCLOSPORINE 0934 CYPROHEPTADINE HYDROCHLORIDE 0940 DANAZOL Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 0944 DANTROLENE SODIUM 0947 DEFEROXAMINE MESYLATE 0951 DEHYDROCHOLIC ACID 0963 DESERPIDINE; METHYCLOTHIAZIDE 0964 DESIPRAMINE HYDROCHLORIDE 0966 DESMOPRESSIN ACETATE 0967 DESONIDE 0968 DESOXIMETASONE 0974 DEXAMETHASONE 0976 DEXAMETHASONE SODIUM PHOSPHATE 0978 DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE 0979 DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 0980 DEXAMETHASONE; TOBRAMYCIN 0982 DEXBROMPHENIRAMINE; PSEUDOEPHEDRINE 0983 DEXCHLORPHENIRAMINE MALEATE 0987 DEXTRAN 0992 DEXTROAMPHETAMINE SULFATE 0994 DEXTROMETHORPHAN HYDROBROMIDE; IODINATED GLYCEROL 0995 DEXTROMETHORPHAN HYDROBROMIDE; PROMETHAZINE HYDROCHLORIDE 1000 DEXTROMETHORPHAN; GUAIFENESIN 1033 DIAZEPAM 1044 DICHLORPHENAMIDE 1045 DICLOFENAC SODIUM 1046 DICLOXACILLIN SODIUM Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1048 DICYCLOMINE HYDROCHLORIDE 1050 DIENESTROL 1053 DIETHYLPROPION HYDROCHLORIDE 1054 DIETHYLSTILBESTROL 1055 DIETHYLSTILBESTROL DIPHOSPHATE 1057 DIFLORASONE DIACETATE 1058 DIFLUNISAL 1060 DIGITOXIN 1061 DIGOXIN 1063 DIHYDROERGOTAMINE MESYLATE 1065 DIHYDROTACHYSTEROL 1068 HYDROCORTISONE; IODOQUINOL 1069 DILTIAZEM HYDROCHLORIDE 1070 DIMENHYDRINATE 1079 DIPHENHYDRAMINE HYDROCHLORIDE 1088 DIPIVEFRIN HYDROCHLORIDE 1090 DIPYRIDAMOLE 1093 DISOPYRAMIDE PHOSPHATE 1096 DIVALPROEX SODIUM 1111 DOXEPIN HYDROCHLORIDE 1113 DOXYCYCLINE 1122 DYPHYLLINE 1124 DYPHYLLINE; GUAIFENESIN 1126 ECHOTHIOPHATE IODIDE 1127 ECONAZOLE NITRATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1138 ENALAPRIL MALEATE 1139 ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE 1141 ENCAINIDE HYDROCHLORIDE 1145 ENZYME(S); HYOSCYAMINE SULFATE; PHENYLTOLOXAMINE CITRATE 1149 EPHEDRINE 1151 EPHEDRINE HYDROCHLORIDE; PHENOBARBITAL; THEOPHYLLINE ANHYDROUS 1152 EPHEDRINE SULFATE; HYDROXYZINE HYDROCHLORIDE; THEOPHYLLINE 1160 EPHEDRINE HYDROCHLORIDE; POTASSIUM IODIDE; PHENOBARBITAL; THEOPHYLLINE 1166 EPINEPHRINE 1169 EPINEPHRYL BORATE 1172 EPINEPHRINE; PILOCARPINE 1173 EPOETIN ALFA 1174 ERGOCALCIFEROL 1175 ERGOLOID MESYLATES 1177 ERGOTAMINE TARTRATE 1178 ERYTHRITYL TETRANITRATE 1179 ERYTHROMYCIN 1180 ERYTHROMYCIN ESTOLATE 1181 ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL 1182 ERYTHROMYCIN ETHYLSUCCINATE 1184 ERYTHROMYCIN LACTOBIONATE 1185 ERYTHROMYCIN STEARATE 1188 ESTRADIOL Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1191 ESTRADIOL VALERATE 1195 ESTRAMUSTINE PHOSPHATE SODIUM 1196 ESTROGENIC SUBSTANCES 1197 ESTROGENS, CONJUGATED 1200 ESTROGENS, ESTERIFIED 1201 ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE 1204 ESTROPIPATE 1206 ETHAMBUTOL HYDROCHLORIDE 1208 ETHAVERINE HYDROCHLORIDE 1213 ETHCHLORVYNOL 1216 ETHINYL ESTRADIOL 1217 ETHINYL ESTRADIOL; ETHYNODIOL DIACETATE 1219 ETHINYL ESTRADIOL; LEVONORGESTREL 1220 ETHINYL ESTRADIOL; NORETHINDRONE 1221 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE; FERROUS FUMARATE 1222 ETHINYL ESTRADIOL; NORGESTREL 1226 ETHOSUXIMIDE 1234 ETIDRONATE DISODIUM 1237 ETRETINATE 1246 FAMOTIDINE 1253 FENOPROFEN CALCIUM 1297 FLAVOXATE HYDROCHLORIDE 1299 FLECAINIDE ACETATE 1301 FLUCONAZOLE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1303 FLUDROCORTISONE ACETATE 1305 FLUNISOLIDE 1306 FLUOCINOLONE ACETONIDE 1310 FLUOCINONIDE 1317 FLUOROMETHOLONE 1319 FLUOROURACIL 1320 FLUOXETINE HYDROCHLORIDE 1321 FLUOXYMESTERONE 1322 FLUPHENAZINE DECANOATE 1324 FLUPHENAZINE HYDROCHLORIDE 1325 FLURANDRENOLIDE 1327 FLURAZEPAM HYDROCHLORIDE 1328 FLURBIPROFEN 1330 FLUTAMIDE 1331 FOLIC ACID 1342 FUROSEMIDE 1351 GEMFIBROZIL 1352 GENTAMICIN SULFATE 1353 GENTAMICIN SULFATE; PREDNISOLONE ACETATE 1357 GLIPIZIDE 1366 GLUTETHIMIDE 1368 GLYBURIDE 1377 GLYCOPYRROLATE 1379 GOLD SODIUM THIOMALATE 1382 GOSERELIN ACETATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1385 GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 1388 GRISEOFULVIN, MICROCRYSTALLINE 1389 GRISEOFULVIN, ULTRAMICROCRYSTALLINE 1391 GUAIFENESIN 1395 GUAIFENESIN; HYDROCODONE BITARTRATE 1402 GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE 1403 GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; PHENYLPROPANOLAMINE HYDROCHLORIDE 1404 GUAIFENESIN; PHENYLPROPANOLAMINE HYDROCHLORIDE 1405 GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE 1406 GUAIFENESIN; PSEUDOEPHEDRINE; THEOPHYLLINE 1407 GUAIFENESIN; THEOPHYLLINE 1408 GUANABENZ ACETATE 1410 GUANETHIDINE MONOSULFATE 1412 GUANFACINE HYDROCHLORIDE 1418 HALOPERIDOL 1419 HALOPERIDOL DECANOATE 1427 HEPARIN LOCK FLUSH 1436 HEXACHLOROPHENE 1440 HISTAMINE PHOSPHATE 1444 HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE 1450 HYDRALAZINE HYDROCHLORIDE 1451 HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE 1452 HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE 1456 HYDROCHLOROTHIAZIDE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1457 HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE 1458 HYDROCHLOROTHIAZIDE; LISINOPRIL 1459 HYDROCHLOROTHIAZIDE; METHYLDOPA 1460 HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE 1461 HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE 1462 HYDROCHLOROTHIAZIDE; RESERPINE 1463 HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 1464 HYDROCHLOROTHIAZIDE; TIMOLOL MALEATE 1465 HYDROCHLOROTHIAZIDE; TRIAMTERENE 1468 HYDROCODONE BITARTRATE; PHENYLEPHRINE HYDROCHLORIDE; PHENYLPROPANOLAMINE HYDROCHLORIDE; PYRILAMINE 1469 HYDROCODONE BITARTRATE; PHENYLEPHRINE HYDROCHLORIDE; PYRILAMINE MALEATE 1470 HYDROCODONE BITARTRATE; PHENYLPROPANOLAMINE HYDROCHLORIDE 1476 HYDROCORTISONE 1477 HYDROCORTISONE ACETATE 1480 HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE 1482 HYDROCORTISONE BUTYRATE 1483 HYDROCORTISONE CYPIONATE 1485 HYDROCORTISONE SODIUM SUCCINATE 1486 HYDROCORTISONE VALERATE 1490 HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 1496 HYDROFLUMETHIAZIDE 1497 HYDROFLUMETHIAZIDE; RESERPINE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1500 HYDROMORPHONE HYDROCHLORIDE 1506 HYDROXYCHLOROQUINE SULFATE 1512 HYDROXYUREA 1513 HYDROXYZINE HYDROCHLORIDE 1514 HYDROXYZINE PAMOATE 1516 HYOSCYAMINE SULFATE 1517 HYOSCYAMINE SULFATE; PHENOBARBITAL 1520 IBUPROFEN 1525 IMIPRAMINE HYDROCHLORIDE 1526 IMIPRAMINE PAMOATE 1529 INDAPAMIDE 1532 INDOMETHACIN 1546 INTERFERON ALFA-2B, RECOMBINANT 1555 IODINATED GLYCEROL 1556 IODINATED GLYCEROL; THEOPHYLLINE 1557 IODINE 1578 IPRATROPIUM BROMIDE 1581 ISOCARBOXAZID 1583 ISOETHARINE MESYLATE 1585 ISONIAZID 1587 ISONIAZID; RIFAMPIN 1590 ISOPROTERENOL HYDROCHLORIDE 1592 ISOSORBIDE 1593 ISOSORBIDE DINITRATE 1595 ISOTRETINOIN Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1596 ISOXSUPRINE HYDROCHLORIDE 1605 KETOCONAZOLE 1606 KETOPROFEN 1607 KETOROLAC TROMETHAMINE 1612 LEVOTHYROXINE SODIUM 1613 LABETALOL HYDROCHLORIDE 1621 LACTULOSE 1630 LEUCOVORIN CALCIUM 1631 LEUPROLIDE ACETATE 1632 LEVAMISOLE HYDROCHLORIDE 1633 LEVOBUNOLOL HYDROCHLORIDE 1634 LEVOCARNITINE 1635 LEVODOPA 1638 LIDOCAINE 1639 LIDOCAINE HYDROCHLORIDE 1641 LINCOMYCIN HYDROCHLORIDE 1642 LINDANE 1645 LIOTHYRONINE SODIUM 1646 LIOTRIX (T4,T3) 1647 LISINOPRIL 1648 LITHIUM CARBONATE 1660 LOMUSTINE 1661 LOPERAMIDE HYDROCHLORIDE 1662 LORAZEPAM 1664 LOVASTATIN Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1666 LOXAPINE SUCCINATE 1677 MAGALDRATE; SIMETHICONE 1695 MANGANESE 1705 MEBENDAZOLE 1708 MECLIZINE HYDROCHLORIDE 1710 MECLOFENAMATE SODIUM 1712 MEDROXYPROGESTERONE ACETATE 1713 MEDRYSONE 1714 MEFENAMIC ACID 1716 MEGESTROL ACETATE 1726 MEPENZOLATE BROMIDE 1727 MEPERIDINE HYDROCHLORIDE 1728 MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE 1731 MEPHOBARBITAL 1734 MEPROBAMATE 1737 MERCAPTOPURINE 1742 MESALAMINE 1744 MESORIDAZINE BESYLATE 1747 METAPROTERENOL SULFATE 1749 METAXALONE 1753 METHADONE HYDROCHLORIDE 1759 METHAZOLAMIDE 1761 METHENAMINE HIPPURATE 1762 METHENAMINE MANDELATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1765 METHIMAZOLE 1767 METHIONINE; SODIUM PROPIONATE; UREA 1768 METHOCARBAMOL 1770 METHOTREXATE SODIUM 1777 METHSUXIMIDE 1778 METHYCLOTHIAZIDE 1780 METHYCLOTHIAZIDE; RESERPINE 1787 METHYLDOPA 1789 METHYLERGONOVINE MALEATE 1790 METHYLPHENIDATE HYDROCHLORIDE 1791 METHYLPREDNISOLONE 1795 METHYLTESTOSTERONE 1798 METOCLOPRAMIDE HYDROCHLORIDE 1800 METOLAZONE 1801 METOPROLOL TARTRATE 1803 METRONIDAZOLE 1806 MEXILETINE HYDROCHLORIDE 1809 MICONAZOLE NITRATE 1818 MINOCYCLINE HYDROCHLORIDE 1819 MINOXIDIL 1820 MISOPROSTOL 1826 MOLINDONE HYDROCHLORIDE 1828 MOMETASONE FUROATE 1833 MORPHINE SULFATE 1843 MUPIROCIN Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1849 NADOLOL 1856 NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE 1858 NANDROLONE DECANOATE 1860 NAPHAZOLINE HYDROCHLORIDE 1861 NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE 1864 NAPROXEN 1865 NAPROXEN SODIUM 1868 NEOMYCIN SULFATE 1869 NEOMYCIN SULFATE; POLYMYXIN B SULFATE 1870 NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PREDNISOLONE ACETATE 1876 NIACIN 1882 NICARDIPINE HYDROCHLORIDE 1884 NICOTINE POLACRILEX 1886 NIFEDIPINE 1890 NITROFURANTOIN 1891 NITROFURANTOIN, MACROCRYSTALLINE 1893 NITROGLYCERIN 1894 NIZATIDINE 1900 NORETHINDRONE ACETATE 1901 NORFLOXACIN 1903 NORTRIPTYLINE HYDROCHLORIDE 1907 NYLIDRIN HYDROCHLORIDE 1908 NYSTATIN 1909 NYSTATIN; TRIAMCINOLONE ACETONIDE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1916 OMEPRAZOLE 1920 ORPHENADRINE CITRATE 1923 OXACILLIN SODIUM 1926 OXAZEPAM 1927 OXICONAZOLE NITRATE 1929 OXTRIPHYLLINE 1930 OXYBUTYNIN CHLORIDE 1932 OXYCODONE HYDROCHLORIDE 1948 PANCREATIN 1949 PANCRELIPASE 1953 PAPAVERINE HYDROCHLORIDE 1960 PAREGORIC 1963 PEMOLINE 1964 PENBUTOLOL SULFATE 1965 PENICILLAMINE 1968 PENICILLIN G POTASSIUM 1971 PENICILLIN V POTASSIUM 1972 PENTAERYTHRITOL TETRANITRATE 1977 PENTAZOCINE LACTATE 1980 PENTOXIFYLLINE 1986 PERGOLIDE MESYLATE 1988 PERPHENAZINE 1995 PHENAZOPYRIDINE HYDROCHLORIDE 1996 PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE 1998 PHENDIMETRAZINE TARTRATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 1999 PHENELZINE SULFATE 2002 PHENIRAMINE; PHENYLPROPANOLAMINE; PYRILAMINE 2003 PHENIRAMINE; PHENYLTOLOXAMINE; PYRILAMINE 2005 PHENOBARBITAL 2013 PHENOXYBENZAMINE HYDROCHLORIDE 2016 PHENTERMINE HYDROCHLORIDE 2019 PHENYLBUTAZONE 2020 PHENYLEPHRINE HYDROCHLORIDE 2021 PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE 2027 PHENYLPROPANOLAMINE HYDROCHLORIDE 2029 PHENYTOIN 2030 PHENYTOIN SODIUM 2035 PHYTONADIONE 2036 PILOCARPINE HYDROCHLORIDE 2038 PIMOZIDE 2039 PINDOLOL 2046 PIRBUTEROL ACETATE 2047 PIROXICAM 2069 POLYTHIAZIDE; PRAZOSIN HYDROCHLORIDE 2070 POLYTHIAZIDE; RESERPINE 2073 POTASSIUM 2078 POTASSIUM BICARBONATE 2081 POTASSIUM CHLORIDE 2084 POTASSIUM GLUCONATE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 2085 POTASSIUM IODIDE 2086 POTASSIUM IODIDE; THEOPHYLLINE ANHYDROUS 2098 PRAZEPAM 2100 PRAZOSIN HYDROCHLORIDE 2102 PREDNISOLONE 2103 PREDNISOLONE ACETATE 2104 PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM 2105 PREDNISOLONE SODIUM PHOSPHATE 2106 PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM 2109 PREDNISONE 2114 PRIMIDONE 2115 PROBENECID 2116 PROBUCOL 2117 PROCAINAMIDE HYDROCHLORIDE 2118 PROCAINE HYDROCHLORIDE 2120 PROCHLORPERAZINE 2122 PROGESTERONE 2125 PROMETHAZINE HYDROCHLORIDE 2127 PROPAFENONE HYDROCHLORIDE 2128 PROPANTHELINE BROMIDE 2133 PROPOXYPHENE HYDROCHLORIDE 2134 PROPOXYPHENE NAPSYLATE 2135 PROPRANOLOL HYDROCHLORIDE 2138 PROPYLTHIOURACIL Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 2143 PROTRIPTYLINE HYDROCHLORIDE 2144 PSEUDOEPHEDRINE HYDROCHLORIDE 2145 PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE 2150 PYRAZINAMIDE 2151 PYRIDOSTIGMINE BROMIDE 2152 PYRIDOXINE HYDROCHLORIDE 2156 PYRIMETHAMINE; SULFADOXINE 2160 QUAZEPAM 2162 QUINESTROL 2165 QUINIDINE GLUCONATE 2166 QUINIDINE POLYGALACTURONATE 2167 QUINIDINE SULFATE 2168 QUININE SULFATE 2174 RANITIDINE HYDROCHLORIDE 2176 RAUWOLFIA SERPENTINA 2179 RESERPINE 2188 RIFAMPIN 2203 SALICYLIC ACID 2206 SALSALATE 2218 SELEGILINE HYDROCHLORIDE 2220 SELENIUM SULFIDE 2241 SODIUM BICARBONATE 2243 SODIUM CHLORIDE 2244 SODIUM FLUORIDE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 2258 SODIUM POLYSTYRENE SULFONATE 2260 SODIUM SULFACETAMIDE; SULFUR 2265 SOMATREM 2267 SORBITOL 2269 SPIRONOLACTONE 2270 STANNOUS FLUORIDE 2271 STANOZOLOL 2280 SUCRALFATE 2282 SULCONAZOLE NITRATE 2283 SULFABENZAMIDE; SULFACETAMIDE; SULFATHIAZOLE 2284 SULFACETAMIDE SODIUM 2287 SULFAMETHIZOLE 2288 SULFAMETHOXAZOLE 2289 SULFAMETHOXAZOLE; TRIMETHOPRIM 2291 SULFAPYRIDINE 2292 SULFASALAZINE 2293 SULFINPYRAZONE 2294 SULFISOXAZOLE 2298 SULINDAC 2306 TAMOXIFEN CITRATE 2310 TEMAZEPAM 2311 TERAZOSIN HYDROCHLORIDE 2312 TERBUTALINE SULFATE 2313 TERCONAZOLE 2314 TERFENADINE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 2318 TESTOSTERONE 2319 TESTOSTERONE CYPIONATE 2326 TETRACYCLINE HYDROCHLORIDE 2329 THEOPHYLLINE 2341 THIORIDAZINE HYDROCHLORIDE 2343 THIOTHIXENE 2348 THYROGLOBULIN 2349 THYROID 2353 TIMOLOL MALEATE 2355 TOBRAMYCIN 2357 TOCAINIDE HYDROCHLORIDE 2358 TOLAZAMIDE 2360 TOLBUTAMIDE 2361 TOLMETIN SODIUM 2366 TRANYLCYPROMINE SULFATE 2367 TRAZODONE HYDROCHLORIDE 2368 TRETINOIN 2370 TRIAMCINOLONE 2371 TRIAMCINOLONE ACETONIDE 2374 TRIAMTERENE 2375 TRIAZOLAM 2376 TRICHLORMETHIAZIDE 2381 TRIETHANOLAMINE POLYPEPTIDE OLEATE CONDENSATE 2382 TRIFLUOPERAZINE HYDROCHLORIDE 2385 TRIHEXYPHENIDYL HYDROCHLORIDE Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 2390 TRIMETHOBENZAMIDE HYDROCHLORIDE 2391 TRIMETHOPRIM 2394 TRIPELENNAMINE HYDROCHLORIDE 2396 TRIPROLIDINE HYDROCHLORIDE 2400 TROPICAMIDE 2418 URSODIOL 2419 VALPROIC ACID 2425 VERAPAMIL HYDROCHLORIDE 2444 WARFARIN SODIUM 2450 YOHIMBINE HYDROCHLORIDE 2451 ZIDOVUDINE 3004 CALCIUM ACETATE 3007 DOXAZOSIN MESYLATE 3009 ESTAZOLAM 3012 HALOBETASOL PROPIONATE 3014 ISRADIPINE 3015 LEVONORGESTREL 3016 OFLOXACIN 3017 OLSALAZINE SODIUM 3022 METIPRANOLOL HYDROCHLORIDE 3024 PEGADEMASE BOVINE 3029 ETODOLAC 3031 ONDANSETRON HYDROCHLORIDE 3032 RAMIPRIL Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 3037 HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE 3046 FILGRASTIM 3052 FOSINOPRIL SODIUM 3053 BENAZEPRIL HYDROCHLORIDE 3059 FELODIPINE 3060 DIDANOSINE 3062 PSEUDOEPHEDRINE HYDROCHLORIDE; TERFENADINE 3063 TICLOPIDINE HYDROCHLORIDE 3064 PRAVASTATIN SODIUM 3066 AZITHROMYCIN DIHYDRATE 3068 CLARITHROMYCIN 3069 QUINAPRIL HYDROCHLORIDE 3072 AMLODIPINE BESYLATE 3076 ZALCITABINE 3078 FINASTERIDE 3084 NEDOCROMIL SODIUM 3087 SERTRALINE HYDROCHLORIDE 3088 SIMVASTATIN 3089 SOTALOL HYDROCHLORIDE 3090 SUMATRIPTAN SUCCINATE 3091 TACRINE HYDROCHLORIDE 3102 CEFPROZIL 3106 ISOSORBIDE MONONITRATE 3107 LORACARBEF Appendix 1 continued Standardized Generic Prescription Medication Names Rx Code Standard Generic Prescription Medication Name ------------------------------------------------------------------------ 3108 NABUMETONE 3109 NICOTINE 3110 NITROFURANTOIN; NITROFURANTOIN, MACROCRYSTALLINE 3126 CEFPODOXIME PROXETIL 3129 CLINDAMYCIN PHOSPHATE 3130 PAROXETINE HYDROCHLORIDE 3133 ITRACONAZOLE 3140 OXAPROZIN 3143 DESOGESTREL; ETHINYL ESTRADIOL 3145 ZOLPIDEM TARTRATE 3149 TERBINAFINE HYDROCHLORIDE 3156 SALMETER